Wall Street lifted targets across multiple sectors on Monday. The upgrades were broad — banks, brokerages, and biotech all moved higher.
HOOD led the pack. The consensus target price rose to $106.02 from $105.46. Robinhood's market cap sits near $89 billion. Short interest is just 5% of free float — bears are not pressing the stock.
Banks swept higher too. JPMorgan Chase saw its average target climb to $351.38. Wells Fargo moved to $97.80. State Street and Northern Trust also got target bumps. The pattern follows strong Q2 earnings across the sector.
In biotech, Moderna drew attention. The average target jumped to $47.37 from $45.85 — a $1.52 move. Short interest on MRNA is high at 16.5% of free float. That sets up a potential squeeze if sentiment keeps turning.
Biogen also got a target lift to $222.45. Incyte edged up to $111.46.
On the downside, ConocoPhillips and Gilead Sciences both saw slight target reductions. COP's consensus slipped to $142.28. GILD fell to $158.41 from $158.48.
The overall tone is constructive. Financials and biotech are where the bullish calls are clustering right now.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
